Stay updated on Atezolizumab Subq in NSCLC: Clinical Trial

Sign up to get notified when there's something new on the Atezolizumab Subq in NSCLC: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Atezolizumab Subq in NSCLC: Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-05-01T05:36:37.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has removed detailed descriptions of a study evaluating atezolizumab for Non-Small Cell Lung Cancer, including specific inclusion and exclusion criteria, while adding a brief mention of the intervention study model and a revision number.
    Difference
    9%
    Check dated 2025-04-16T14:36:09.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to January 24, 2025.
    Difference
    0.2%
    Check dated 2025-04-09T09:42:59.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version (v2.14.3) and a more recent last update date of March 25, 2025, replacing the previous version (v2.14.2) and its last update date of January 24, 2025.
    Difference
    0.2%
    Check dated 2025-04-01T23:32:07.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.8%
    Check dated 2025-02-24T21:16:29.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.8%
    Check dated 2025-02-10T10:24:49.000Z thumbnail image

Stay in the know with updates to Atezolizumab Subq in NSCLC: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Atezolizumab Subq in NSCLC: Clinical Trial page.